CERO THERAPEUTICS HOLDINGS INC
For the period ended Mar 31, 2024. Filed May 17, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 17, 2024
CERO$0.010.0%Stored close · as of Jul 8, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| CERO THERAPEUTICS HOLDINGS, INC. | ||
| Date: May 17, 2024 | By: | /s/ Brian G. Atwood |
|---|---|---|
| Name: | Brian G. Atwood | |
| Title: | Chairman, Chief Executive Officer and Director | |
| (Principal Executive Officer) | ||
| Date: May 17, 2024 | By: | /s/ Charles R. Carter |
| Name: | Charles R. Carter | |
| Title: | Chief Financial Officer, Treasurer and Secretary | |
| (Principal Financial and Accounting Officer) | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.